Osteoporosis: Molecular Pathology, Diagnostics, and Therapeutics
- PMID: 37834025
- PMCID: PMC10572718
- DOI: 10.3390/ijms241914583
Osteoporosis: Molecular Pathology, Diagnostics, and Therapeutics
Abstract
Osteoporosis is a major public health concern affecting millions of people worldwide and resulting in significant economic costs. The condition is characterized by changes in bone homeostasis, which lead to reduced bone mass, impaired bone quality, and an increased risk of fractures. The pathophysiology of osteoporosis is complex and multifactorial, involving imbalances in hormones, cytokines, and growth factors. Understanding the cellular and molecular mechanisms underlying osteoporosis is essential for appropriate diagnosis and management of the condition. This paper provides a comprehensive review of the normal cellular and molecular mechanisms of bone homeostasis, followed by an in-depth discussion of the proposed pathophysiology of osteoporosis through the osteoimmunological, gut microbiome, and cellular senescence models. Furthermore, the diagnostic tools used to assess osteoporosis, including bone mineral density measurements, biochemical markers of bone turnover, and diagnostic imaging modalities, are also discussed. Finally, both the current pharmacological and non-pharmacological treatment algorithms and management options for osteoporosis, including an exploration of the management of osteoporotic fragility fractures, are highlighted. This review reveals the need for further research to fully elucidate the molecular mechanisms underlying the condition and to develop more effective therapeutic strategies.
Keywords: bone homeostasis; cellular mechanisms; cytokines; hormones; models; osteoporosis; pathophysiology.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

Similar articles
-
Bone health in childhood and adolescence: an overview on dual-energy X-ray absorptiometry scanning, fracture surveillance and bisphosphonate therapy for low-middle-income countries.Front Endocrinol (Lausanne). 2023 Apr 17;14:1082413. doi: 10.3389/fendo.2023.1082413. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37139332 Free PMC article. Review.
-
The Effects of Osteoporotic and Non-osteoporotic Medications on Fracture Risk and Bone Mineral Density.Drugs. 2021 Nov;81(16):1831-1858. doi: 10.1007/s40265-021-01625-8. Epub 2021 Nov 1. Drugs. 2021. PMID: 34724173 Free PMC article. Review.
-
Male osteoporosis.Reumatismo. 2014 Jul 28;66(2):136-43. doi: 10.4081/reumatismo.2014.786. Reumatismo. 2014. PMID: 25069495 Review.
-
[The effects of glucocorticoid on bone architecture and strength].Clin Calcium. 2013 Jul;23(7):993-9. Clin Calcium. 2013. PMID: 23811587 Review. Japanese.
-
Closing the gap in osteoporosis management: the critical role of primary care in bone health.Curr Med Res Opin. 2023 Mar;39(3):387-398. doi: 10.1080/03007995.2022.2141483. Epub 2023 Jan 24. Curr Med Res Opin. 2023. PMID: 36597741 Review.
Cited by
-
Identification and experimental validation of programmed cell death- and mitochondria-associated biomarkers in osteoporosis and immune microenvironment.Front Genet. 2024 Jul 26;15:1439171. doi: 10.3389/fgene.2024.1439171. eCollection 2024. Front Genet. 2024. PMID: 39130750 Free PMC article.
-
The role of magnesium in the pathogenesis of osteoporosis.Front Endocrinol (Lausanne). 2024 Jun 6;15:1406248. doi: 10.3389/fendo.2024.1406248. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38904051 Free PMC article. Review.
-
Effects of high-impact jumping versus resistance exercise on bone mineral content in children and adolescents: a systematic review and meta-analysis.PeerJ. 2025 Jun 30;13:e19616. doi: 10.7717/peerj.19616. eCollection 2025. PeerJ. 2025. PMID: 40611942 Free PMC article.
-
Application of extracellular vesicles in diabetic osteoporosis.Front Endocrinol (Lausanne). 2024 Dec 10;15:1466775. doi: 10.3389/fendo.2024.1466775. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39720256 Free PMC article. Review.
-
Posttranslational Modification in Bone Homeostasis and Osteoporosis.MedComm (2020). 2025 Apr 1;6(4):e70159. doi: 10.1002/mco2.70159. eCollection 2025 Apr. MedComm (2020). 2025. PMID: 40170748 Free PMC article. Review.
References
-
- Rosen C.J. The Epidemiology and Pathogenesis of Osteoporosis. In: Feingold K.R., Anawalt B., Boyce A., Blackman M.R., Chrousos G., Corpas E., de Herder W.W., Dhatariya K., Dungan K., Hofland J., et al., editors. Endotext. MDText.com, Inc.; South Dartmouth, MA, USA: 2000. [(accessed on 9 January 2023)]. Available online: http://www.ncbi.nlm.nih.gov/books/NBK279134/
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical